Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

SNSS

Sunesis Pharmaceuticals (SNSS)

Sunesis Pharmaceuticals Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:SNSS
DateTimeSourceHeadlineSymbolCompany
06/05/20086:25PMEdgar (US Regulatory)Sunesis Pharmaceuticals Inc - Amended Statement of Changes in Beneficial Ownership (4/A)NASDAQ:SNSSSunesis Pharmaceuticals Inc
06/05/20086:16PMEdgar (US Regulatory)Sunesis Pharmaceuticals Inc - Statement of Changes in Beneficial Ownership (4)NASDAQ:SNSSSunesis Pharmaceuticals Inc
06/05/20085:20PMEdgar (US Regulatory)Sunesis Pharmaceuticals Inc - Statement of Changes in Beneficial Ownership (4)NASDAQ:SNSSSunesis Pharmaceuticals Inc
06/05/20085:11PMEdgar (US Regulatory)Sunesis Pharmaceuticals Inc - Statement of Changes in Beneficial Ownership (4)NASDAQ:SNSSSunesis Pharmaceuticals Inc
06/05/20084:57PMEdgar (US Regulatory)Sunesis Pharmaceuticals Inc - Statement of Changes in Beneficial Ownership (4)NASDAQ:SNSSSunesis Pharmaceuticals Inc
06/05/20084:52PMEdgar (US Regulatory)Sunesis Pharmaceuticals Inc - Statement of Changes in Beneficial Ownership (4)NASDAQ:SNSSSunesis Pharmaceuticals Inc
06/05/20084:27PMEdgar (US Regulatory)Sunesis Pharmaceuticals Inc - Statement of Changes in Beneficial Ownership (4)NASDAQ:SNSSSunesis Pharmaceuticals Inc
06/05/20084:07PMEdgar (US Regulatory)Sunesis Pharmaceuticals Inc - Statement of Changes in Beneficial Ownership (4)NASDAQ:SNSSSunesis Pharmaceuticals Inc
06/03/20084:21PMPR Newswire (US)Sunesis Pharmaceuticals Focuses Resources on Development of Voreloxin (Formerly SNS-595)NASDAQ:SNSSSunesis Pharmaceuticals Inc
06/03/20084:19PMPR Newswire (US)Sunesis Pharmaceuticals Expands Development Leadership Team to Focus on Late-Stage Development of Voreloxin (Formerly SNS-595)NASDAQ:SNSSSunesis Pharmaceuticals Inc
05/31/200810:00AMPR Newswire (US)Sunesis Pharmaceuticals Presents Updated Clinical Data From Ongoing Phase 2 Trial of Voreloxin (Formerly SNS-595) in Ovarian CanNASDAQ:SNSSSunesis Pharmaceuticals Inc
05/31/200810:00AMPR Newswire (US)Sunesis Pharmaceuticals Presents Updated Clinical Data From Ongoing Phase 2 Trial of Voreloxin (Formerly SNS-595) in Ovarian CanNASDAQ:SNSSSunesis Pharmaceuticals Inc
05/28/20089:00AMPR Newswire (US)Sunesis Pharmaceuticals to Present Interim Clinical Data From Voreloxin (Formerly SNS-595) Ovarian Cancer Trial at 44th ASCO AnnNASDAQ:SNSSSunesis Pharmaceuticals Inc
05/21/20088:00AMPR Newswire (US)Sunesis Pharmaceuticals Initiates Phase 2 Clinical Trial of Voreloxin (SNS-595) in Acute Myeloid LeukemiaNASDAQ:SNSSSunesis Pharmaceuticals Inc
05/13/20088:00AMPR Newswire (US)Sunesis Pharmaceuticals to Present at the Rodman & Renshaw 5th Annual Global Healthcare ConferenceNASDAQ:SNSSSunesis Pharmaceuticals Inc
05/12/20082:11PMEdgar (US Regulatory)Sunesis Pharmaceuticals Inc - Securities Registration: Employee Benefit Plan (S-8)NASDAQ:SNSSSunesis Pharmaceuticals Inc
05/09/20084:21PMEdgar (US Regulatory)Sunesis Pharmaceuticals Inc - Quarterly Report (10-Q)NASDAQ:SNSSSunesis Pharmaceuticals Inc
05/08/20089:03AMEdgar (US Regulatory)Sunesis Pharmaceuticals Inc - Current report filing (8-K)NASDAQ:SNSSSunesis Pharmaceuticals Inc
05/08/20088:00AMPR Newswire (US)Sunesis Pharmaceuticals Reports First Quarter 2008 Financial ResultsNASDAQ:SNSSSunesis Pharmaceuticals Inc
04/30/20089:30AMPR Newswire (US)Sunesis Pharmaceuticals to Report Financial Results for the First Quarter on May 8, 2008NASDAQ:SNSSSunesis Pharmaceuticals Inc
04/29/20081:07PMEdgar (US Regulatory)Sunesis Pharmaceuticals Inc - Proxy Statement (definitive) (DEF 14A)NASDAQ:SNSSSunesis Pharmaceuticals Inc
04/16/20089:30AMPR Newswire (US)Sunesis Pharmaceuticals Reports Data from Nonclinical Studies of SNS-032 at the Annual Meeting of the American Association for CNASDAQ:SNSSSunesis Pharmaceuticals Inc
04/14/20085:05PMPR Newswire (US)Sunesis Pharmaceuticals Presents Nonclinical Data on SNS-595 at the Annual Meeting of the American Association for Cancer ResearNASDAQ:SNSSSunesis Pharmaceuticals Inc
03/17/20083:17PMEdgar (US Regulatory)Sunesis Pharmaceuticals Inc - Annual Report (10-K)NASDAQ:SNSSSunesis Pharmaceuticals Inc
03/13/20088:00AMPR Newswire (US)Sunesis Pharmaceuticals to Present at Healthcare Investor Conferences in MarchNASDAQ:SNSSSunesis Pharmaceuticals Inc
03/11/20085:06PMEdgar (US Regulatory)Sunesis Pharmaceuticals Inc - Current report filing (8-K)NASDAQ:SNSSSunesis Pharmaceuticals Inc
03/11/20088:38AMEdgar (US Regulatory)Sunesis Pharmaceuticals Inc - Current report filing (8-K)NASDAQ:SNSSSunesis Pharmaceuticals Inc
03/11/20088:00AMPR Newswire (US)Sunesis Pharmaceuticals Reports Fourth Quarter and Full-Year 2007 Financial ResultsNASDAQ:SNSSSunesis Pharmaceuticals Inc
03/10/20088:00AMPR Newswire (US)Sunesis Pharmaceuticals Reports Positive Interim Data for SNS-595 Single-Agent Activity in Platinum-Resistant Ovarian CancerNASDAQ:SNSSSunesis Pharmaceuticals Inc
03/05/20088:00AMPR Newswire (US)Sunesis Pharmaceuticals to Report Fourth Quarter and Full-Year 2007 Financial Results on March 11, 2008NASDAQ:SNSSSunesis Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:SNSS

Your Recent History

Delayed Upgrade Clock